Willemijn van der Spuij
Executive Director Europe, Worldwide Patient Safety, Bristol Myers Squibb & Chair of EFPIA International PV Group
Willemijn van der Spuij is the Executive Director Europe in the Worldwide Patient Safety Organisation in Bristol Myers Squibb. She is responsible for Patient Safety in the EU markets, Balkans, Baltics and CIS region and is based in Switzerland. Prior to her current role she held responsibilities for PV Intelligence & International Operations including the PSMF, the EU QPPV role and Training and Outsourcing activities. Willemijn holds a Nursing Degree from the Netherlands, a BA (Hons) in Sociology from Goldsmiths college, University of London, UK and an MSc in Pharmacovigilance from the University of Hertfordshire, UK. She is a member of the EFPIA Pharmacovigilance Expert Working Group and Chair of the EFPIA International Pharmacovigilance Group. Willemijn started her career in pharma in Quintiles with a focus on GCP activities and joined BMS in 2003 focusing on GVP activities.